AbbVie | 8-K: Current report
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E
AbbVie | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
AbbVie | 8-K: Current report
AbbVie | SD: Specialized disclosure report
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
AbbVie | 8-K: Current report
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director FALK THOMAS J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director MEYER MELODY B
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director FREYMAN THOMAS C
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Hart Brett J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Roberts Rebecca B
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Davis Jennifer L.
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director WADDELL FREDERICK H
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director BURNSIDE WILLIAM H.L.
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director AUSTIN ROXANNE S
AbbVie | 10-Q: Q1 2026 Earnings Report